Aug. 04, 2023
MONTPELLIER, FRANCE – French biotechnology company Sensorion has secured €35 million in private placement financing to fund the development of innovative therapies for hearing loss disorders. The financing involves the issuance of new ordinary shares and pre-funded warrants to investors, including Redmile Group, a US-based healthcare investor, and existing shareholders Invus and Sofinnova Partners. Nawal Ouzren, the CEO of Sensorion,